Publications

5808 Results

SWOG 0421: Impact of circulating markers of bone metabolism on overall survival in men with metastatic castration resistant prostate cancer (CRPC)

Authors
PN Lara;M Plets;C Tangen;E Gertz;DI Quinn;I Thompson;M Van Loan
Journal / Conference
European Multidisciplinary Meeting on Urological Cancers (EMUC)(Nov 12-15, 2015, Barcelona, Spain), oral presentation; abst O6
Year
2015
Research Committee(s)
Genitourinary
Study Number(s)
S0421

Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG

Authors
R Walter;M Othus;B Lowenberg;G Ossenkoppele;S Petersdorf;T Pabst;M-C Vekemans;F Appelbaum;H Erba;E Estey
Journal / Conference
Haematologica Oct;100(10):e409-11
Year
2015
Research Committee(s)
Leukemia
PMID
PMID26160876
PMC
PMC4591777
Study Number(s)
S0106

Event-free and overall survival following neoadjuvant weekly paclitaxel and dose-dense AC +/- carboplatin and/or bevacizumab in triple-negative breast cancer: outcomes from CALGB 40603 (Alliance)

Authors
W Sikov;DA Berry;C Perou;B Singh;C Cirrincione;S Tolaney;G Somlo;E Port;R Qamar;K Sturtz;E Mamounas;M Golshan;J Bellon;D Collyar;O Hahn;L Carey;C Hudis;E Winer
Journal / Conference
San Antonio Breast Cancer Symposium 2015 (Dec 8-12, 2015, San Antonio, TX), oral, abst. S2-05;
Year
2015
Research Committee(s)
Breast
Study Number(s)
CTSU/C40603

Multi-center US intergroup study of intensive chemotherapy plus dasatinib followed by allogeneic stem cell transplant in patients with Philadelphia chromosome positive acute lymphoblastic leukemia younger than 60

Authors
F Ravandi;M Othus;S O'Brien;S Forman;C Ha;J Wong;M Tallman;E Paietta;J Racevskis;G Uy;U Borate;P Kebriaei;L Kingsbury;JP Radich;HM Kantarjian;H Erba;FR Appelbaum
Journal / Conference
Blood 126(23):796; American Society of Hematology Annual Meeting (Dec 5-8, 2015, Orlando, FL),oral presentation;
Year
2015
Research Committee(s)
Leukemia
Study Number(s)
S0805

Bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (pts) with previously untreated multiple myeloma without an intent for immediate autologous stem cell transplant (ASCT): results of the randomized phase III trial SWOG S0777

Authors
B Durie;A Hoering;SV Rajkumar;M Abidi;J Epstein;S Kahanic;M Thakuri;F Reu;C Reynolds;R Sexton;R Orlowski;B Barlogie;A Dispenzieri
Journal / Conference
Blood 126(23):25; American Society of Hematology Annual Meeting (Dec 5-8, 2015, Orlando, FL), oral;
Year
2015
Research Committee(s)
Myeloma
Study Number(s)
S0777

Pre-transplant R-Bendamustine induces high rates of minimal residual disease in MCL patients: Updated results of SWOG S1106: US intergroup study of a randomized phase II trial of R-HCVAD vs. R-bendamustine followed by autologous stem cell transplants for patients with mantle cell lymphoma

Authors
RW Chen;H Li;S Bernstein;L Rimsza;S Forman;L Constine;T Shea;A Cashen;C Blum;T Fenske;P Barr;M Leblanc;RI Fisher;B Cheson;S Smith;M Faham;J Wilkins;JP Leonard;B Kahl;J Friedberg
Journal / Conference
Blood 126(23):518; American Society of Hematology Annual Meeting (Dec 5-8, 2015, Orlando, FL), oral;
Year
2015
Research Committee(s)
Lymphoma
Study Number(s)
S1106

Results of US intergroup trial of response-adapted chemotherapy based on PET for non-bulky stage I and II hodgkin lymphoma (HL) (CALGB/Alliance 50604) (http://www.bloodjournal.org/content/126/23/578)

Authors
D Straus;BN Pitcher;L Kostakoglu;J Grecula;E Hsi;H Schoder;S-H Jung;LL Popplewell;JP Leonard;J Friedberg;B Kahl;B Cheson;N Bartlett
Journal / Conference
Blood 126(23):578; American Society of Hematology Annual Meeting (Dec 5-8, Orlando, FL), oral;
Year
2015
Research Committee(s)
Lymphoma

Report of the relapsed/refractory cohort of SWOG S0919: phase 2 study of idarubicin and cytarabine in combination with pravastatin for acute myelogenous leukemia (AML)

Authors
A Advani;H Li;L Michaelis;B Medeiros;M Liedtke;A List;K O'Dwyer;M Othus;HP Erba;FR Appelbaum
Journal / Conference
Blood 126(23):3803; American Society of Hematology Annual Meeting (Dec 5-8, 2015, poster;
Year
2015
Research Committee(s)
Leukemia
Study Number(s)
S0919

A phase I/II trial of vorinostat (SAHA) in combination with rituximab-CHOP in patients with newly diagnosed advanced stage diffuse large b-cell lymphoma (DLBCL): SWOG S0806

Authors
D Persky;H Li;L Rimsza;P Barr;L Popplewell;C Bane;A Von Gehr;M Leblanc;RI Fisher;S Smith;J Friedberg
Journal / Conference
American Society of Hematology Annual Meeting (Dec 5-8, Orlando, FL), poster;
Year
2015
Research Committee(s)
Lymphoma
Study Number(s)
S0806

Effect of minimal residual disease (MRD) information on prediction of relapse and survival in adult acute myeloid leukemia (SWOG S0106)

Authors
M Othus;B Wood;E Estey;S Petersdorf;F Appelbaum;H Erba;R Walter
Journal / Conference
Blood 126(23):2569; American Society of Hematology Annual Meeting (Dec 5-8, 2015, Orlando, FL), poster;
Year
2015
Research Committee(s)
Leukemia
Study Number(s)
S0106